United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-7385_4c5ca171-2a1c-4687-adf9-6d272463de4a
- Product NDC
- 0093-7385
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100701
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7385-05) · 0093-7385-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7385-56) · 0093-7385-56
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7385-98) · 0093-7385-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →